ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.
Dev Cell
; 57(11): 1331-1346.e9, 2022 06 06.
Article
in En
| MEDLINE
| ID: mdl-35508175
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Transcription Factors
/
Carcinoma, Pancreatic Ductal
/
LIM-Homeodomain Proteins
/
Nerve Tissue Proteins
Limits:
Humans
Language:
En
Journal:
Dev Cell
Year:
2022
Document type:
Article